IMBDX

Innovative liquid biopsy platform
with industry-leading performance

Revolutionary genomic & epigenomic
analyses for the early detection of cancer

Precision oncology solutions
throughout the full continuum of
cancer care

AlphaLiquid®

Read More 이동
  • The most widely adopted liquid biopsy platform in Korea

  • Industry leading test performance based on proprietary bioinformatics

  • Robustly validated through clinical studies